Boothbay Fund Management’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $682K | Sell |
|
|||||
|
2024
Q3 | $1.19M | Hold |
|
|||||
|
2024
Q2 | $1.18M | Sell |
|
|||||
|
2024
Q1 | $1.31M | Sell |
|
|||||
|
2023
Q4 | $1.85M | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $384K | Sell |
|
|||||
|
2023
Q1 | $423K | Hold |
|
|||||
|
2022
Q4 | $466K | Hold |
|
|||||
|
2022
Q3 | $427K | Sell |
|
|||||
|
2022
Q2 | $800K | Buy |
|
|||||
|
2022
Q1 | $744K | Buy |
|
|||||
|
2021
Q4 | $574K | Sell |
|
|||||
|
2021
Q3 | $784K | Sell |
|
|||||
|
2021
Q2 | $1.78M | Buy |
|
|||||
|
2021
Q1 | $1.63M | Buy |
|
|||||
|
2020
Q4 | $654K | Buy |
|
|||||
|
2020
Q3 | $404K | Sell |
|
|||||
|
2020
Q2 | $560K | Sell |
|
|||||
|
2020
Q1 | $737K | Buy |
|
|||||
|
2019
Q4 | $669K | Hold |
|
|||||
|
2019
Q3 | $460K | Sell |
|
|||||
|
2019
Q2 | $510K | Sell |
|
|||||
|
2019
Q1 | $753K | Buy |
|
|||||
|
2018
Q4 | $219K | Buy |
|
|||||
|
2018
Q3 | $254K | Sell |
|
|||||
|
2018
Q2 | $325K | Buy |
|